Vietnam pharmaceuticals market is bound to experience impressive growth with anticipated CAGR in the forecast period, 2022-2026, on the account of increasing development of the medicinal drugs and pharmaceutical products. Consistent research and drug discovery procedures are going on currently. Vietnam is one of the rapidly evolving and economically stabilizing countries. With cheap labor for the production and manufacturing of the pharmaceutical drugs and products, the Vietnam pharmaceuticals market is anticipated to grow in the next five years. Additionally, emergence of new technologies, cost-effective, and more efficient manufacturing processes are also driving the growth of the Vietnam pharmaceuticals market in the future five years. Also, increased government funding and private investment have impacted the growth in the industry. Technological advancement and consistent research in the robotic technology and artificial intelligence have worked on the reduction of product manufacturing waste. Single-use disposable solutions, along with the paradigm shift towards smart, integrated, data-rich paperless operations have resulted in the error-free and precise production of the pharmaceuticals thereby supporting the growth of the Vietnam pharmaceutical market in the future five years. Also, penetration from the global players in the Vietnam market is supporting the growth of the industry as well as the Vietnam pharmaceutical market in the forecast years.

Pharmaceutical includes all sorts of medicinal, diagnostic, treatment, and prognosis material substance. These substances are also used for the restoring, correcting, or modifying the organic functions. The pharmaceutical products are often standardized and approved by Food and Drug Administration (FDA) prior to its commercialization and application to common population. According to some reliable resources, the Vietnam healthcare expenditures are anticipated to account for more than 12% of the total GDP of the country by the end of 2021.

The Vietnam pharmaceuticals market is segmented by drug type, product type, application, distribution channel, competitional landscape, and regional distribution. Based on drug type, the market is further divided between generic drugs, and branded drugs. Generic drugs are anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years on the account of abundance of the market players dealing in the same in the market. Moreover, the healthcare industry in the country is still expanding ad developing. The accessibility for the generic drugs is wider as compared to branded drugs. Branded drugs are anticipated to hold the significant shares of the market on the account of increasing number of market players in the industry. Moreover, rapidly increasing penetration in the market by global players is also flooding the market with branded drugs and thereby supporting he growth of the segment as well as the Vietnam pharmaceutical market in the next five years.

A partial list of market player in the Vietnam pharmaceuticals market includes DHG Pharmaceutical Joint Stock Company, Traphaco Joint Stock Company, Pymepharco Joint Stock Company, Hatay Pharmaceutical Joint Stock Company, Mekophar Chemical Pharmaceutical JSC, Imexpharm Corporation, OPC Pharmaceutical Joint Stock Company, among others. These market players hold larger shares of the market than the new market players. With the evolving technology, it is appropriate to say that the effective research and development of the technologically advanced pharmaceuticals and methods to satisfy consumer demands would support the market growth and benefit the market players as well as the consumers. New market players may focus on the research and development to provide such infrastructure and services that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: 2016 – 2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022 – 2026

Objective of the Study:

  • To analyze the historical growth of the market size of Vietnam pharmaceuticals market from 2016 to 2019.
  • To estimate and forecast the market size of Vietnam pharmaceuticals market from 2020 to 2026 and growth rate until 2026. 
  • To classify and forecast Vietnam pharmaceuticals market based on market drug type, product type, application, distribution channel, competitional landscape, and regional distribution.
  • To identify dominant region or segment in the Vietnam pharmaceuticals market.
  • To identify drivers and challenges for Vietnam pharmaceuticals market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Vietnam pharmaceuticals market.
  • To identify and analyze the profile of leading players operating in Vietnam pharmaceuticals market.
  • To identify key sustainable strategies adopted by market players in Vietnam pharmaceuticals market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of pharmaceuticals, suppliers, and service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of Vietnam pharmaceuticals market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Pharmaceuticals, service provider, infrastructure producers, end users, and other stakeholders
  • Distributors and suppliers of the products and other stakeholders
  • Organizations, forums, and alliances related to pharmaceuticals
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as pharmaceuticals, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, Vietnam pharmaceuticals market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Vietnam Pharmaceuticals Market, By Drug Type:

o   Generic Drugs

o   Branded Drugs

  • Vietnam Pharmaceuticals Market, By Product Type:
    • Prescription Drugs
    • Over-The-Counter Drugs
  • Vietnam Pharmaceuticals Market, By Application:
    • Cardiovascular
    • Musculoskeletal
    • Oncology
    • Anti-infective
    • Metabolic Disorder
    • Others
  • Vietnam Pharmaceuticals Market, By Distribution Channel:
    • Retail Pharmacy
    • Hospital Pharmacy
    • E-Pharmacy
  • Vietnam Pharmaceuticals Market, By Region:
    • Northern
    • Central
    • Southern

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Vietnam pharmaceuticals market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Vietnam Pharmaceuticals Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

1.     Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Vietnam Pharmaceutical Market

4.    Executive Summary

5.    Voice of Customers

6.    Vietnam Pharmaceutical Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Drug Type (Generic Drugs v/s Branded Drugs)

6.2.2.     By Product Type (Prescription Drugs v/s Over-The-Counter Drugs)

6.2.3.     By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)

6.2.4.     By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

6.2.5.     By Region

6.2.6.     By Company (2020)

6.3.  Product Market Map

7.    Vietnam Generic Drugs Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Product Type

7.2.2.     By Application

7.2.3.     By Distribution Channel

8.    Vietnam Branded Drugs Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Product Type

8.2.2.     By Application

8.2.3.     By Distribution Channel

9.    Market Dynamics

9.1.  Drivers

9.2.  Challenges

10.  Market Trends & Developments

11.  Policy & Regulatory Landscape

12.  Vietnam Economic Profile

13.  Competitive Landscape

13.1.              Competition Outlook

13.2.              Company Profiles

13.2.1.  DHG Pharmaceutical Joint Stock Company

13.2.2.  Traphaco Joint Stock Company

13.2.3.  Pymepharco Joint Stock Company

13.2.4.  Hatay Pharmaceutical Joint Stock Company

13.2.5.  Mekophar Chemical Pharmaceutical JSC

13.2.6.  Imexpharm Corporation

13.2.7.  OPC Pharmaceutical Joint Stock Company

14.  Strategic Recommendations

15. About Us & Disclaimer